Leadless Pacemaker Systems Market Size, Share, Growth, Forecast 2030

Leadless Pacemaker Systems Market

Leadless Pacemaker Systems Market- By Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker, and Others) and By End-User (Hospitals and Ambulatory Surgical Units): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2022 – 2028

Category: Medical Device Report Format : PDF Pages: 122 Report Code: ZMR-6998 Published Date: Apr-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 55 Million USD 98 Million 10.1% 2020

Leadless Pacemaker Systems Market

The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028.

The study provides assessment and analysis of the Leadless Pacemaker Systems Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Million).

Leadless Pacemaker Systems Market: Overview

Leadless pacemaker systems are self-contained generators & electrode systems implanted directly into right ventricle of human body. The device is inserted through femoral vein transcatheter approach and needs no chest incision and sub-cutaneous generator pocket. Key benefit of leadless pacemaker system is eliminating large number of complications related to transvenous pacemakers & leads, hematoma, lead fracture, pocket infections, and lead dislodgement. Leadless pacemakers can be suited to patients having permanent atrial fibrillation due to bradycardia or those that need pacing regularly. However, leadless pacemaker systems are not appropriate for subjects requiring dual-chamber pacing. For instance, patients having particular kinds of heart block as well as sinus node dysfunction.

Global Leadless Pacemaker Systems MarketRequest Free Sample

Leadless Pacemaker Systems Market: Growth Drivers

Surge in cardiovascular diseases and increase in geriatric population prone to heart ailments will create huge scope of growth for leadless pacemaker systems industry. Favorable reimbursement policies and elongated battery life has made use of leadless pacemaker systems popular in healthcare sector. Breakthroughs in pacemaker technology and growing tilt towards minimally invasive surgeries & treatment will pave a way for massive growth of leadless pacemaker systems industry in ensuing years. Supportive government laws promoting healthcare activities along with surge in allocation of funds for healthcare industry will drive expansion of leadless pacemaker systems market. Nonetheless, high implantation costs and lack of trained personnel for performing leadless pacemaker implants can pose a threat to expansion of leadless pacemaker systems industry.

Leadless Pacemaker Systems Market: Report Scope

Report Attributes Report Details
Report Name Leadless Pacemaker Systems Market Research Report
Market Size in 2021 USD 55 Million
Market Forecast in 2028 USD 98 Million
Growth Rate CAGR of 10.1%
Number of Pages 210
Key Companies Covered Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation
Segments Covered By Product Type, By End User and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2020
Historical Year 2016 to 2020
Forecast Year 2020 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Furthermore, no threat of scars & infections and MRI compatibility will translate into huge growth of leadless pacemaker systems industry. No requirement of post-operative mobility restriction will further steer growth of leadless pacemaker systems market. Product innovations and launching of new technologies in healthcare sector will create lucrative opportunities for leadless pacemaker systems industry.

Leadless Pacemaker Systems Market: Competitive Landscape

Key players establishing a deeper impact on leadless pacemaker systems market growth and included in report are Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation.

Leadless Pacemaker Systems Market: Regional Landscape

North America Contributed Immensely Towards Regional Market Share By 2028

Expansion of leadless pacemaker systems industry in North America over forecasting timeline is subject to rise in occurrence of heart ailments along with swift acceptance of leadless cardiac pacemakers. Additionally, favorable compensation policies and surge in number of patients suffering from atrial fibrillation will translate into humungous growth of regional market.

Global Leadless Pacemaker Systems Market SizeRequest Free Sample

Apart from this, large-scale presence of giant medical device manufacturing firms in sub-continent has contributed majorly towards leadless pacemaker systems market rewards in North America.

Leadless Pacemaker Systems Market: Competitive Space

The global Leadless Pacemaker Systems market profiles key players such as:

  • Abbott Laboratories
  • Biotronik
  • Medtronic PLC
  • EBR Systems Inc
  • Boston Scientific Corporation

The global Leadless Pacemaker Systems Market is segmented as follows:

By Product

  • Micra Transcatheter Pacing System
  • Nanostim Leadless Pacemaker
  • Others

 By End-User

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Surge in cardiovascular diseases and increase in geriatric population prone to heart ailments will create huge scope of growth for leadless pacemaker systems industry.

 

According to Zion market research report, The global Leadless Pacemaker Systems Market accrued earnings worth approximately 55 (USD Million) in 2021 and is predicted to gain revenue of about 98 (USD Million) by 2028, is set to record a CAGR of nearly 10.1% over the period from 2022 to 2028.

North America will contribute sizably towards the global industry revenue over the projected timeline. Expansion of leadless pacemaker systems industry in North America over forecasting timeline is subject to rise in occurrence of heart ailments along with swift acceptance of leadless cardiac pacemakers.

The key industry participants leveraging industry sphere include Abbott Laboratories, Biotronik, Medtronic PLC, EBR Systems, Inc., and Boston Scientific Corporation.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed